Re: your comment- "If I am mistaken and Ziv was sl
Post# of 15624
(Total Views: 323)
Posted On: 04/19/2017 10:12:13 PM
Re: HumanBeing #7525
Re: your comment- "If I am mistaken and Ziv was slated 10,000,000 options in this latest 10K please correct me."
On page 66 of the 10-K, re: Ziv Turner. I am assuming that #3 "Former Managing Director of the subsidiary" refers to Ziv Turner. Am I mistaken here in making this assumption? However, at the bottom of this list it states: "All 5 officers are serving in the Company and subsidiary since 2014". Was Ziv Turner with the company in 2014 and perhaps promoted in 2016?
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (cont.)
NOTE 13 - RELATED PARTY TRANSACTIONS
1. Chairmen and CEO of both parent and subsidiary, serves as employee of the subsidiary with compensation of $3,000 per month. In addition, he was awarded 10,000,000 options through the 2016 ESOP which vest over two years.
2. CFO of both parent and subsidiary receives compensation of $3,000 per month. In addition, he was awarded 750,000 options through the 2016 ESOP which vest over two years.
3. Former Managing Director of the subsidiary, received compensation of $3,000 per month. In addition, he was awarded 10,000,000 options through the 2016 ESOP which vest over two years
4. Chief Science Officer and Director of Research and Regulatory Affairs, receives compensation of $3,000 per month. In addition, he was awarded 7,000,000 options through the 2016 ESOP which vest over two years
5. COO and Interim CEO of subsidiary, receives compensation of $3,000 per month. In addition, he was awarded 7,000,000 options through the 2016 ESOP which vest over two years.
All 5 officers are serving in the Company and subsidiary since 2014. All are entitled to receive 60 days early notification of ending working relation and employee rights according to Israeli law, including severance pay.
On page 66 of the 10-K, re: Ziv Turner. I am assuming that #3 "Former Managing Director of the subsidiary" refers to Ziv Turner. Am I mistaken here in making this assumption? However, at the bottom of this list it states: "All 5 officers are serving in the Company and subsidiary since 2014". Was Ziv Turner with the company in 2014 and perhaps promoted in 2016?
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (cont.)
NOTE 13 - RELATED PARTY TRANSACTIONS
1. Chairmen and CEO of both parent and subsidiary, serves as employee of the subsidiary with compensation of $3,000 per month. In addition, he was awarded 10,000,000 options through the 2016 ESOP which vest over two years.
2. CFO of both parent and subsidiary receives compensation of $3,000 per month. In addition, he was awarded 750,000 options through the 2016 ESOP which vest over two years.
3. Former Managing Director of the subsidiary, received compensation of $3,000 per month. In addition, he was awarded 10,000,000 options through the 2016 ESOP which vest over two years
4. Chief Science Officer and Director of Research and Regulatory Affairs, receives compensation of $3,000 per month. In addition, he was awarded 7,000,000 options through the 2016 ESOP which vest over two years
5. COO and Interim CEO of subsidiary, receives compensation of $3,000 per month. In addition, he was awarded 7,000,000 options through the 2016 ESOP which vest over two years.
All 5 officers are serving in the Company and subsidiary since 2014. All are entitled to receive 60 days early notification of ending working relation and employee rights according to Israeli law, including severance pay.
(1)
(0)OWC Pharmaceutical Research Corp. (OWCP) Stock Research Links
Scroll down for more posts ▼